Recent evidences showed that elevation of plasminogen activator inhibitor 1 (PAI-1) was responsible in mediating obesity-induced non-alcoholic fatty liver disease (NAFLD) and metabolic disorders. The gene discussed is SERPINE1; the disease is obesity due to melanocortin 4 receptor deficiency.